*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter - as a primary diagnosis code | T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.12 | |
| Readmission Rate (%) | 21.38 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 21 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter in DRG | 52.5 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 3.38 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $96,526 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $1,360 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $4,596 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $570,865 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $27,184 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 61.9 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,522,684 | ||||
| Total Hospitalizations with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 292 | ||||
| DRG Share of Total Hospitalizations | 4.63 | ||||
| % of Total ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter in DRG | 4.95 | ||||
| Avg LOS at DRG | 2.52 | ||||
| Avg LOS with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 3.13 | ||||
| Readmission Rate at DRG | 9.03 | ||||
| Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 8.8 | ||||
| Unplanned Readmission Rate at DRG | 3.35 | ||||
| Unplanned Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| Total Medicare payments at DRG | $17,672,828,347 | ||||
| Total Medicare payments with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $3,490,554 | ||||
| Total Medicare payment per Day at DRG | $4,606 | ||||
| Total Medicare payment per Day with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $3,819 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,606 | ||||
| Total Medicare payment per Hospitalization with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $11,954 | ||||
| Total Medicare Charges at DRG | $91,836,200,128 | ||||
| Total Medicare Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $17,733,929 | ||||
| Avg Charges at DRG | $60,312 | ||||
| Avg Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $60,733 | ||||
| Mortality Rate at DRG | 0.05 | ||||
| Mortality Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 23.53 | ||||
| SNF Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 27.74 | ||||
| Home Discharge Rate at DRG | 30.67 | ||||
| Home Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 27.05 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 312: SYNCOPE AND COLLAPSE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 101,617 | ||||
| Total Hospitalizations with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 145 | ||||
| DRG Share of Total Hospitalizations | 0.31 | ||||
| % of Total ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter in DRG | 2.46 | ||||
| Avg LOS at DRG | 9.5 | ||||
| Avg LOS with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 5.12 | ||||
| Readmission Rate at DRG | 26.88 | ||||
| Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 23.7 | ||||
| Unplanned Readmission Rate at DRG | 19.26 | ||||
| Unplanned Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 12.59 | ||||
| Total Medicare payments at DRG | $1,599,186,807 | ||||
| Total Medicare payments with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $1,512,370 | ||||
| Total Medicare payment per Day at DRG | $1,656 | ||||
| Total Medicare payment per Day with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $2,035 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,737 | ||||
| Total Medicare payment per Hospitalization with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $10,430 | ||||
| Total Medicare Charges at DRG | $4,836,538,333 | ||||
| Total Medicare Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $6,560,565 | ||||
| Avg Charges at DRG | $47,596 | ||||
| Avg Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $45,245 | ||||
| Mortality Rate at DRG | 2.8 | ||||
| Mortality Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 20.21 | ||||
| SNF Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 30.34 | ||||
| Home Discharge Rate at DRG | 20.17 | ||||
| Home Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 35.17 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 408,103 | ||||
| Total Hospitalizations with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 99 | ||||
| DRG Share of Total Hospitalizations | 1.24 | ||||
| % of Total ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter in DRG | 1.68 | ||||
| Avg LOS at DRG | 3.52 | ||||
| Avg LOS with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 3.65 | ||||
| Readmission Rate at DRG | 17.83 | ||||
| Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| Unplanned Readmission Rate at DRG | 13.81 | ||||
| Unplanned Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| Total Medicare payments at DRG | $2,416,862,532 | ||||
| Total Medicare payments with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $524,484 | ||||
| Total Medicare payment per Day at DRG | $1,682 | ||||
| Total Medicare payment per Day with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $1,453 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,922 | ||||
| Total Medicare payment per Hospitalization with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $5,298 | ||||
| Total Medicare Charges at DRG | $13,267,744,847 | ||||
| Total Medicare Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $3,322,555 | ||||
| Avg Charges at DRG | $32,511 | ||||
| Avg Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $33,561 | ||||
| Mortality Rate at DRG | 0.72 | ||||
| Mortality Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 14.1 | ||||
| SNF Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 15.15 | ||||
| Home Discharge Rate at DRG | 62.97 | ||||
| Home Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 66.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 093: OTHER DISORDERS OF NERVOUS SYSTEM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,799 | ||||
| Total Hospitalizations with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 69 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter in DRG | 1.17 | ||||
| Avg LOS at DRG | 5.74 | ||||
| Avg LOS with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 2.54 | ||||
| Readmission Rate at DRG | 14.93 | ||||
| Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| Unplanned Readmission Rate at DRG | 8.84 | ||||
| Unplanned Readmission Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| Total Medicare payments at DRG | $370,803,163 | ||||
| Total Medicare payments with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $292,537 | ||||
| Total Medicare payment per Day at DRG | $1,476 | ||||
| Total Medicare payment per Day with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $1,672 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,466 | ||||
| Total Medicare payment per Hospitalization with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $4,240 | ||||
| Total Medicare Charges at DRG | $1,198,628,374 | ||||
| Total Medicare Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $1,963,912 | ||||
| Avg Charges at DRG | $27,367 | ||||
| Avg Charges with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | $28,462 | ||||
| Mortality Rate at DRG | 0.2 | ||||
| Mortality Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 16.4 | ||||
| SNF Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 21.74 | ||||
| Home Discharge Rate at DRG | 42.3 | ||||
| Home Discharge Rate with ICD T391X5A - Adverse effect of 4-Aminophenol derivatives, initial encounter | 49.28 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| DECATUR MEMORIAL HOSPITAL | 2300 N. EDWARD ST. | DECATUR | IL | 62526 | 42 |
| RUSH UNIVERSITY MEDICAL CENTER | 1653 W CONGRESS PKWY | CHICAGO | IL | 60612 | 34 |
| RIVERSIDE MEDICAL CENTER | 350 N WALL ST | KANKAKEE | IL | 60901 | 28 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | E785 | Hyperlipidemia, unspecified |
| 2 | I10 | Essential (primary) hypertension |